Found 20 matching trials
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases PHASE1 Patients have a type of a lymph node cancer called lymphoma, a tumor of the...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies N/A The primary objective of this protocol is to provide expanded access to tab...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma PHASE1 RATIONALE: Biological therapies use different ways to stimulate the immune ...
Show More Location
Penn State Cancer Institute at Milton S. Hershey Medical Center
Learn More & Join Trial
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies PHASE1 The purpose of this study is to test the safety of giving the patient speci...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies PHASE1 The purpose of this phase I/II trial is to study the side effects and best ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy PHASE3 The purpose of this study is to determine the clinical benefit and characte...
Show More Location
City of Hope (Adults and Pediatrics)
Learn More & Join Trial
EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases PHASE1 In this multi-center open-label, non-randomized phase I/II intervention stu...
Show More Location
University Hospital Basel, Klinik für Infektiologie und Spitalhygiene
Learn More & Join Trial
Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants PHASE1 RATIONALE: Donor lymphocytes that have been exposed to Epstein-Barr virus m...
Show More Location
University of Alabama Comprehensive Cancer Center
Learn More & Join Trial
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV PHASE1 This protocol is a phase I study. Patients may be eligible for an infusion ...
Show More Location
Medical College of Wisconsin
Learn More & Join Trial
Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China PHASE1 Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) cause significant morbid...
Show More Location
Affiliated Hospital to Academy of Military Medical Sciences
Learn More & Join Trial